Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
December 10, 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
July 14, 2025
Press Releases
Foley Adds Litigation Partner Matt Caplan in San Francisco, Strengthening Technology and Health Care Sector Capabilities
Foley & Lardner LLP announced today that Matt Caplan has joined the firm’s San Francisco office as a partner in its Commercial Litigation Practice Group and Innovative Technology and Health Care & Life Sciences Sectors.
July 8, 2025
Press Releases
Foley Expands Tax Capabilities with Addition of Partner David Morris in Salt Lake City
Foley & Lardner LLP announced today that David Morris has joined the firm’s Salt Lake City office as a partner in its Taxation Practice Group.
June 5, 2025
Press Releases
Foley Secures Top Rankings in Chambers USA 2025
Foley & Lardner LLP is proud to once again be recognized by Chambers & Partners as one of the leading law firms in the country in the 2025 edition of Chambers USA: America’s Leading Lawyers for Business.